(Q41588317)

4 October 2017

0 references

1 reference

title

Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke (English)

1 reference

4 October 2017

1 reference

1 reference

1

J M Wardlaw

1 reference

4 October 2017

C P Warlow

2

1 reference

PubMed ID

9288042

4 October 2017

C Counsell

series ordinal

3

1 reference

PubMed ID

9288042

4 October 2017

language of work or name

English

0 references

publication date

1 August 1997

1 reference

4 October 2017

1 reference

4 October 2017

350

1 reference

4 October 2017

607-614

1 reference

4 October 2017

9078

1 reference

Thrombolysis with fibrinolysin in cerebral arterial occlusion.

4 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903022-5

7 January 2021

Thrombolysis in acute ischemic stroke: does it work?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903022-5

7 January 2021

Thrombolytic therapy with streptokinase in acute ischemic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903022-5

7 January 2021

Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903022-5

7 January 2021

Tissue plasminogen activator for acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903022-5

7 January 2021

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903022-5

7 January 2021

Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Hea

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903022-5

7 January 2021

Multicentre Acute Stroke Trial--Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903022-5

7 January 2021

Trials of streptokinase in severe acute ischaemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903022-5

7 January 2021

Why do we need systematic overviews of randomized trials?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903022-5

7 January 2021

Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. The TPA Bridging Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903022-5

7 January 2021

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903022-5

7 January 2021

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903022-5

7 January 2021

Controversies in meta-analysis: the case of the trials of serum cholesterol reduction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903022-5

7 January 2021

THERAPEUTIC THROMBOLYSIS IN CEREBRAL THROMBOEMBOLISM. DOUBLE-BLIND EVALUATION OF INTRAVENOUS PLASMIN THERAPY IN CAROTID AND MIDDLE CEREBRAL ARTERIAL OCCLUSION

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903022-5

7 January 2021

ANTICOAGULANTS PLUS STREPTOKINASE THERAPY IN PROGRESSIVE STROKE

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903022-5

7 January 2021

Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903022-5

7 January 2021

The relation between treatment benefit and underlying risk in meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903022-5

7 January 2021

Mortality by cause for eight regions of the world: Global Burden of Disease Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903022-5

7 January 2021

A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903022-5

7 January 2021

Patient preferences for stroke outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903022-5

7 January 2021

10.1016/S0140-6736(97)03022-5

Identifiers

DOI

1 reference

4 October 2017

1 reference

PubMed ID

9288042